Abbott Laboratories vs. Fortress Biotech, Inc.
Abbott Laboratories (ABT) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| ABT | FBIO | |
|---|---|---|
| Market Cap | $182.92 billion | $92.68 million |
| Revenue (TTM) | — | $66.16 million |
| Net Income (TTM) | — | $128.94 million |
ABT leads on 1 of 1 size & scale factors.
Valuation
| ABT | FBIO | |
|---|---|---|
| P/E Ratio | — | 0.88 |
| Price / Book | — | 0.46 |
| Price / Sales | — | 1.40 |
ABT and FBIO split the valuation factors evenly.
Profitability
| ABT | FBIO | |
|---|---|---|
| Net Margin | — | 194.89% |
| Return on Equity | — | 63.71% |
ABT and FBIO split the profitability factors evenly.
Risk & Sentiment
| ABT | FBIO | |
|---|---|---|
| Short Interest | 0.57% | 3.18% |
ABT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, FBIO overview, FBIO financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.
